We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+10.36%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$33.3B
AUM Growth
+$2.42B
Cap. Flow
-$747M
Cap. Flow %
-2.24%
Top 10 Hldgs %
22.18%
Holding
833
New
90
Increased
211
Reduced
362
Closed
78

Sector Composition

Rank Sector Weight
1 Technology 15.05%
2 Financials 12.44%
3 Healthcare 12.21%
4 Consumer Discretionary 9.72%
5 Industrials 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOW icon
526
ServiceNow
NOW
$129B
$3.25M 0.01%
290,270
-34,465
-11% -$364K
NSP icon
527
Insperity
NSP
$2.01B
$3.23M 0.01%
+178,858
New +$3.21M
LGF
528
DELISTED
Lions Gate Entertainment
LGF
$3.2M 0.01%
100,981
-105,597
-51% -$3.48M
HAIN icon
529
Hain Celestial
HAIN
$53.7M
$3.16M 0.01%
+69,556
New +$2.88M
N
530
DELISTED
Netsuite Inc
N
$3.1M 0.01%
30,109
-8,497
-22% -$852K
SBGI icon
531
Sinclair Inc
SBGI
$1.03B
$3.1M 0.01%
86,616
+26,456
+44% +$890K
FLS icon
532
Flowserve
FLS
$10.2B
$3.09M 0.01%
+39,201
New +$2.72M
SRCL
533
DELISTED
Stericycle Inc
SRCL
$3.04M 0.01%
26,123
+379
+1% +$44.2K
ATHN
534
DELISTED
Athenahealth, Inc.
ATHN
$3M 0.01%
22,331
+1,823
+9% +$234K
ALXN
535
DELISTED
Alexion Pharmaceuticals
ALXN
$2.94M 0.01%
+22,106
New +$2.65M
YELP icon
536
Yelp
YELP
$1.41B
$2.85M 0.01%
41,333
+2,771
+7% +$183K
GSK icon
537
GSK
GSK
$106B
$2.76M 0.01%
41,302
+15,957
+63% +$1.03M
KLAC icon
538
KLA
KLAC
$259B
$2.74M 0.01%
424,620
+29,050
+7% +$183K
HSBC icon
539
HSBC
HSBC
$356B
$2.65M 0.01%
55,713
+11,273
+25% +$534K
DXCM icon
540
DexCom
DXCM
$32B
$2.64M 0.01%
298,348
+25,868
+9% +$205K
EQNR icon
541
Equinor
EQNR
$92.4B
$2.62M 0.01%
108,620
+24,845
+30% +$573K
INCY icon
542
Incyte
INCY
$24.4B
$2.56M 0.01%
50,569
+50,015
+9,028% +$2.18M
BTI icon
543
British American Tobacco
BTI
$128B
$2.52M 0.01%
46,936
+9,098
+24% +$484K
PBYI icon
544
Puma Biotechnology
PBYI
$454M
$2.51M 0.01%
24,233
-8,114
-25% -$476K
REGN icon
545
Regeneron Pharmaceuticals
REGN
$80.8B
$2.43M 0.01%
8,825
+1,019
+13% +$293K
P
546
DELISTED
Pandora Media Inc
P
$2.35M 0.01%
88,387
+21,519
+32% +$590K
ICPT
547
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.33M 0.01%
+34,057
New +$1.97M
ABBV icon
548
AbbVie
ABBV
$435B
$2.26M 0.01%
42,777
-367,234
-90% -$18M
IWM icon
549
iShares Russell 2000 ETF
IWM
$83B
$2.16M 0.01%
+18,728
New +$2.07M
SI
550
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$2.12M 0.01%
15,289
+6,805
+80% +$876K

Similar funds

Loomis, Sayles & Company's Q4 2013 Portfolio in Review

As of Q4 2013, Loomis, Sayles & Company held 833 positions worth $33.3B, up 7.8% from $30.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Loomis, Sayles & Company's Q4 2013 filing shows 90 new, 211 increased, 362 reduced and 78 closed positions. Its largest new stake was Eli Lilly: 1,920,841 shares worth $98M. The largest sale was GENERAL MTRS CO JR PFD CONV SER B (DE), an estimated $580M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Loomis, Sayles & Company's largest Q4 2013 buy was Eli Lilly: 1,920,841 shares worth $98M.
  • Loomis, Sayles & Company added most to General Motors in Q4 2013, an estimated $620M increase.
  • Loomis, Sayles & Company's biggest Q4 2013 reduction was EOG Resources, cutting an estimated $147M.
  • Loomis, Sayles & Company fully exited GENERAL MTRS CO JR PFD CONV SER B (DE) in Q4 2013, selling an estimated $580M.
  • Loomis, Sayles & Company's ten largest holdings make up 22% of its $33.3B portfolio in Q4 2013.
  • Loomis, Sayles & Company opened 90 new positions and closed 78 in Q4 2013.
  • Loomis, Sayles & Company's portfolio value rose 7.8% quarter-over-quarter to $33.3B.

Based on Loomis, Sayles & Company's 13F filing for Q4 2013, filed 12 Feb 2014.